Prognostic impact of CD133 expression in Endometrial Cancer Patients

To assess the impact of CD133 expression on the prognosis of endometrioid endometrial carcinoma (EEC). We retrospectively assessed CD133 expression in tissue microarray of 116 surgically treated FIGO I-III EEC. Tumors with ≥10% of CD133-expressing cells were considered CD133-positive (CD133+). On th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancebo, G., Sole-Sedeno, J. M., Pino, O., Miralpeix, E., Mojal, S., Garrigos, L., Lloveras, B., Navarro, P., Gibert, J., Lorenzo, M., Aran, I., Carreras, R., Alameda, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550511/
https://www.ncbi.nlm.nih.gov/pubmed/28794448
http://dx.doi.org/10.1038/s41598-017-08048-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550511/
https://www.ncbi.nlm.nih.gov/pubmed/28794448
http://dx.doi.org/10.1038/s41598-017-08048-0

Ejemplares similares